User profiles for Ben Spilseth
 | Benjamin D SpilsethUniversity of Minnesota Verified email at umn.edu Cited by 829 |
Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the society of abdominal radiology prostate cancer disease …
…, NU Patel, PA Pinto, TJ Polascik, B Spilseth… - Radiology, 2020 - pubs.rsna.org
Background Prostate MRI is used widely in clinical care for guiding tissue sampling, active
surveillance, and staging. The Prostate Imaging Reporting and Data System (PI-RADS) helps …
surveillance, and staging. The Prostate Imaging Reporting and Data System (PI-RADS) helps …
Diagnostic performance of contrast-enhanced MRI with secretin-stimulated MRCP for non-calcific chronic pancreatitis: a comparison with histopathology
…, SP Walker, S Munigala, B Spilseth… - Official journal of the …, 2015 - journals.lww.com
OBJECTIVES: Diagnosis of non-calcific chronic pancreatitis (NCCP) in patients presenting
with chronic abdominal pain is challenging and controversial. Contrast-enhanced magnetic …
with chronic abdominal pain is challenging and controversial. Contrast-enhanced magnetic …
Detection of prostate cancer: quantitative multiparametric MR imaging models developed using registered correlative histopathology
Purpose To develop multiparametric magnetic resonance (MR) imaging models to generate
a quantitative, user-independent, voxel-wise composite biomarker score (CBS) for detection …
a quantitative, user-independent, voxel-wise composite biomarker score (CBS) for detection …
Use of MRI for lobar classification of benign prostatic hyperplasia: potential phenotypic biomarkers for research on treatment strategies
NF Wasserman, B Spilseth… - American Journal of …, 2015 - Am Roentgen Ray Soc
OBJECTIVE. We present an MRI classification of benign prostatic hyperplasia (BPH) for use
as a phenotype biomarker in the study of proposed therapeutic interventions. CONCLUSION…
as a phenotype biomarker in the study of proposed therapeutic interventions. CONCLUSION…
Which scores need a core? An evaluation of MR-targeted biopsy yield by PIRADS score across different biopsy indications
Introduction Magnetic resonance imaging is being widely adopted in the clinical management
of prostate cancer. The correlation of the Prostate Imaging Reporting and Data System (…
of prostate cancer. The correlation of the Prostate Imaging Reporting and Data System (…
[HTML][HTML] Contrast enhanced MRI in the diagnosis of HCC
E Niendorf, B Spilseth, X Wang, A Taylor - Diagnostics, 2015 - mdpi.com
Hepatocellular carcinoma (HCC) is the 6th most common cancer worldwide. Imaging plays
a critical role in HCC screening and diagnosis. Initial screening of patients at risk for HCC is …
a critical role in HCC screening and diagnosis. Initial screening of patients at risk for HCC is …
[HTML][HTML] Measurement of prostate volume with MRI (a guide for the perplexed): biproximate method with analysis of precision and accuracy
NF Wasserman, E Niendorf, B Spilseth - Scientific reports, 2020 - nature.com
To review the anatomic basis of prostate boundary selection on T2-weighted magnetic
resonance imaging (MRI). To introduce an alternative 3D ellipsoid measuring technique that …
resonance imaging (MRI). To introduce an alternative 3D ellipsoid measuring technique that …
A comparison of radiologists' and urologists' opinions regarding prostate MRI reporting: results from a survey of specialty societies
B Spilseth, S Ghai, NU Patel… - American Journal of …, 2018 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this study is to compare radiologists' and urologists' opinions
regarding prostate MRI reporting. SUBJECTS AND METHODS. Radiologist members of the …
regarding prostate MRI reporting. SUBJECTS AND METHODS. Radiologist members of the …
Multiparametric prostate MRI: focus on T2-weighted imaging and role in staging of prostate cancer
RT Gupta, B Spilseth, N Patel, AF Brown, J Yu - Abdominal Radiology, 2016 - Springer
Multiparametric MRI (mpMRI) represents a growing modality for the non-invasive evaluation
of prostate cancer (PCa) and is increasingly being used for patients with persistently …
of prostate cancer (PCa) and is increasingly being used for patients with persistently …
MRI in differentiating malignant versus benign portal vein thrombosis in patients with hepatocellular carcinoma: value of post contrast imaging with subtraction
…, D Olgun, L Krystosek, N Rubin, B Spilseth - European journal of …, 2019 - Elsevier
Purpose To evaluate MR imaging parameters including quantitative multiphasic post-contrast
enhancement with subtraction and qualitative diffusion weighted imaging (DWI) in …
enhancement with subtraction and qualitative diffusion weighted imaging (DWI) in …